Systemic inflammation and liver damage in HIV/hepatitis C virus coinfection. Issue 8 (17th May 2016)
- Record Type:
- Journal Article
- Title:
- Systemic inflammation and liver damage in HIV/hepatitis C virus coinfection. Issue 8 (17th May 2016)
- Main Title:
- Systemic inflammation and liver damage in HIV/hepatitis C virus coinfection
- Authors:
- Shmagel, KV
Saidakova, EV
Shmagel, NG
Korolevskaya, LB
Chereshnev, VA
Robinson, J
Grivel, J‐C
Douek, DC
Margolis, L
Anthony, DD
Lederman, MM - Abstract:
- Abstract : Objectives: Chronic hepatitis C virus (HCV) and HIV viral infections are characterized by systemic inflammation. Yet the relative levels, drivers and correlates of inflammation in these settings are not well defined. Methods: Seventy‐nine HIV‐infected patients who had been receiving antiretroviral therapy (ART) for more than 2 years and who had suppressed plasma HIV levels (< 50 HIV‐1 RNA copies/mL) were included in the study. Two patient groups, HCV‐positive/HIV‐positive and HCV‐negative/HIV‐positive, and a control group comprised of healthy volunteers ( n = 20) were examined. Markers of systemic inflammation [interleukin (IL)‐6, interferon gamma‐induced protein (IP)‐10, soluble tumour necrosis factor receptor‐I (sTNF‐RI) and sTNF‐RII], monocyte/macrophage activation [soluble CD163 (sCD163), soluble CD14 and neopterin], intestinal epithelial barrier loss [intestinal fatty acid binding protein (I‐FABP) and lipopolysaccharide (LPS)] and coagulation (d ‐dimers) were analysed. CD4 naïve T cells and CD4 recent thymic emigrants (RTEs) were enumerated. Results: Plasma levels of IP‐10, neopterin and sCD163 were higher in HCV/HIV coinfection than in HIV monoinfection and were positively correlated with indices of hepatic damage [aspartate aminotransferase (AST), alanine aminotransferase (ALT) and the AST to platelet ratio index (APRI)]. Levels of I‐FABP were comparably increased in HIV monoinfection and HIV/HCV coinfection but LPS concentrations were highest in HCV/HIVAbstract : Objectives: Chronic hepatitis C virus (HCV) and HIV viral infections are characterized by systemic inflammation. Yet the relative levels, drivers and correlates of inflammation in these settings are not well defined. Methods: Seventy‐nine HIV‐infected patients who had been receiving antiretroviral therapy (ART) for more than 2 years and who had suppressed plasma HIV levels (< 50 HIV‐1 RNA copies/mL) were included in the study. Two patient groups, HCV‐positive/HIV‐positive and HCV‐negative/HIV‐positive, and a control group comprised of healthy volunteers ( n = 20) were examined. Markers of systemic inflammation [interleukin (IL)‐6, interferon gamma‐induced protein (IP)‐10, soluble tumour necrosis factor receptor‐I (sTNF‐RI) and sTNF‐RII], monocyte/macrophage activation [soluble CD163 (sCD163), soluble CD14 and neopterin], intestinal epithelial barrier loss [intestinal fatty acid binding protein (I‐FABP) and lipopolysaccharide (LPS)] and coagulation (d ‐dimers) were analysed. CD4 naïve T cells and CD4 recent thymic emigrants (RTEs) were enumerated. Results: Plasma levels of IP‐10, neopterin and sCD163 were higher in HCV/HIV coinfection than in HIV monoinfection and were positively correlated with indices of hepatic damage [aspartate aminotransferase (AST), alanine aminotransferase (ALT) and the AST to platelet ratio index (APRI)]. Levels of I‐FABP were comparably increased in HIV monoinfection and HIV/HCV coinfection but LPS concentrations were highest in HCV/HIV coinfection, suggesting impaired hepatic clearance of LPS. Plasma HCV levels were not related to any inflammatory indices except sCD163. In coinfected subjects, a previously recognized relationship of CD4 naïve T‐cell and RTE counts to hepatocellular injury was defined more mechanistically by an inverse relationship to sCD163. Conclusions: Hepatocellular injury in HCV/HIV coinfection is linked to elevated levels of certain inflammatory cytokines and an apparent failure to clear systemically translocated microbial products. A related decrease in CD4 naïve T cells and RTEs also merits further exploration. … (more)
- Is Part Of:
- HIV medicine. Volume 17:Issue 8(2016:Sep.)
- Journal:
- HIV medicine
- Issue:
- Volume 17:Issue 8(2016:Sep.)
- Issue Display:
- Volume 17, Issue 8 (2016)
- Year:
- 2016
- Volume:
- 17
- Issue:
- 8
- Issue Sort Value:
- 2016-0017-0008-0000
- Page Start:
- 581
- Page End:
- 589
- Publication Date:
- 2016-05-17
- Subjects:
- antigens -- CD31 -- hepatitis C -- highly active antiretroviral therapy -- HIV infections -- inflammation mediators
HIV infections -- Treatment -- Periodicals
HIV-positive persons -- Periodicals
HIV infections -- Treatment -- Decision making -- Periodicals
616.9792 - Journal URLs:
- http://www.blackwell-synergy.com/member/institutions/issuelist.asp?journal=hiv ↗
http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1468-1293 ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1111/hiv.12357 ↗
- Languages:
- English
- ISSNs:
- 1464-2662
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 4319.045900
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 1780.xml